Koers Cadila Healthcare Limited Bombay S.E.
Aandelen
CADI
INE010B01019
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- INR | - |
Omzet 2024 | 195 mld. 2,35 mld. 2,16 mld. | Omzet 2025 * | 217 mld. 2,61 mld. 2,41 mld. | Marktkapitalisatie | 1.060 mld. 12,74 mld. 11,73 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 | 38,6 mld. 464 mln. 427 mln. | Nettowinst (verlies) 2025 * | 42,66 mld. 513 mln. 472 mln. | EV/omzet 2024 | 5,19 x |
Nettoliquiditeiten 2024 * | 13,47 mld. 162 mln. 149 mln. | Nettoliquiditeiten 2025 * | 29,52 mld. 355 mln. 327 mln. | EV/omzet 2025 * | 4,74 x |
K/w-verhouding 2024 |
26,4
x | K/w-verhouding 2025 * |
25,3
x | Werknemers | - |
Dividendrendement 2024 * |
0,55% | Dividendrendement 2025 * |
0,51% | Vrij verhandelbaar | 24,87% |
Recentste transcriptie over Cadila Healthcare Limited
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 44 | 01-08-97 | |
Director of Finance/CFO | - | - | |
Chairman | 71 | 15-05-95 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 72 | 06-12-18 | |
Chairman | 71 | 15-05-95 | |
Director/Board Member | 69 | 01-08-97 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,31% | 42,32 mld. | |
+16,32% | 21,29 mld. | |
+19,33% | 15,29 mld. | |
+18,71% | 14,36 mld. | |
-0,05% | 6,79 mld. | |
-12,24% | 6,58 mld. | |
-8,87% | 5,73 mld. | |
+11,64% | 5,51 mld. | |
+7,31% | 4,91 mld. |
- Beurs
- Aandelen
- Koers ZYDUSLIFE
- Koers CADI